The anti-inflammatory protein annexin 1 may protect patients from the detrimental effects of severe inflammatory response syndrome, as reported by researchers at Barts and the London, Queen Mary’s School of Medicine and Dentistry. The paper by Damazo et al., “Critical protective role for annexin 1 gene expression in the endotoxemic murine microcirculation,” appears in the June issue of The American Journal of Pathology and is accompanied by a commentary.
